267,508 Shares in Astera Labs, Inc. $ALAB Bought by Nuveen LLC

Key Points

• Nuveen LLC has invested approximately $15.96 million in Astera Labs by acquiring 267,508 shares, representing 0.16% ownership as of their latest filing.
• Astera Labs has received positive attention from analysts, with price targets ranging from $100 to $170 and a consensus rating of "Moderate Buy."
• Insider selling activity has been notable, with COO Sanjay Gajendra selling 280,000 shares for a total of $47.6 million, reducing his ownership by 4.82%.

Nuveen LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 267,508 shares of the company's stock, valued at approximately $15,962,000. Nuveen LLC owned approximately 0.16% of Astera Labs as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. NewEdge Advisors LLC purchased a new stake in shares of Astera Labs during the 4th quarter worth $63,000. Banque Transatlantique SA purchased a new stake in shares of Astera Labs in the 4th quarter worth about $86,000. Emerald Mutual Fund Advisers Trust boosted its position in shares of Astera Labs by 429.3% in the 4th quarter. Emerald Mutual Fund Advisers Trust now owns 704 shares of the company's stock worth $93,000 after buying an additional 571 shares in the last quarter. Gen Wealth Partners Inc purchased a new stake in shares of Astera Labs in the 4th quarter worth about $105,000. Finally, Sound Income Strategies LLC boosted its position in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Needham & Company LLC boosted their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a research report on Saturday, August 16th. Northland Securities lowered shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective on the stock. in a research report on Tuesday, July 22nd. William Blair started coverage on shares of Astera Labs in a research report on Thursday, May 22nd. They issued an "outperform" rating on the stock. Finally, Morgan Stanley upped their target price on shares of Astera Labs from $125.00 to $155.00 and gave the company an "overweight" rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs has a consensus rating of "Moderate Buy" and an average target price of $129.13.

Astera Labs Stock Performance

ALAB traded down $3.3240 on Monday, reaching $175.7660. 2,340,405 shares of the company's stock were exchanged, compared to its average volume of 4,958,298. The company's 50 day moving average is $123.97 and its 200-day moving average is $92.74. The company has a market cap of $29.22 billion, a price-to-earnings ratio of 313.49, a PEG ratio of 4.54 and a beta of 1.39. Astera Labs, Inc. has a twelve month low of $36.85 and a twelve month high of $199.47.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company's revenue was up 149.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Activity

In other Astera Labs news, CEO Jitendra Mohan sold 91,441 shares of the company's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the transaction, the chief executive officer owned 2,170,877 shares in the company, valued at $398,377,638.27. This represents a 4.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael Truett Tate sold 18,861 shares of the company's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $3,461,182.11. Following the completion of the transaction, the chief financial officer owned 259,512 shares of the company's stock, valued at approximately $47,623,047.12. This represents a 6.78% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,385,416 shares of company stock worth $298,063,981. Insiders own 12.50% of the company's stock.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.